LDR Capital Management LLC Sells 160,260 Shares of Global Medical REIT Inc. $GMRE

LDR Capital Management LLC cut its holdings in Global Medical REIT Inc. (NYSE:GMREFree Report) by 91.5% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 14,846 shares of the company’s stock after selling 160,260 shares during the quarter. Global Medical REIT makes up about 0.7% of LDR Capital Management LLC’s investment portfolio, making the stock its 28th largest position. LDR Capital Management LLC owned approximately 0.11% of Global Medical REIT worth $500,000 at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in the business. Geode Capital Management LLC lifted its position in shares of Global Medical REIT by 3.0% in the 2nd quarter. Geode Capital Management LLC now owns 1,748,799 shares of the company’s stock worth $12,121,000 after purchasing an additional 50,959 shares during the period. Invesco Ltd. raised its stake in Global Medical REIT by 30.5% in the second quarter. Invesco Ltd. now owns 1,518,668 shares of the company’s stock worth $10,524,000 after buying an additional 355,355 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in Global Medical REIT by 8.6% during the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 1,514,954 shares of the company’s stock worth $10,499,000 after buying an additional 119,538 shares during the period. Man Group plc lifted its holdings in Global Medical REIT by 1.7% during the second quarter. Man Group plc now owns 600,943 shares of the company’s stock worth $4,165,000 after buying an additional 10,192 shares during the period. Finally, Cutler Capital Management LLC boosted its position in Global Medical REIT by 3.5% during the 2nd quarter. Cutler Capital Management LLC now owns 472,938 shares of the company’s stock valued at $3,277,000 after acquiring an additional 15,900 shares in the last quarter. Hedge funds and other institutional investors own 57.52% of the company’s stock.

Insider Transactions at Global Medical REIT

In other news, CEO Mark Okey Decker, Jr. purchased 10,000 shares of the company’s stock in a transaction that occurred on Friday, November 14th. The shares were bought at an average price of $32.58 per share, for a total transaction of $325,800.00. Following the completion of the transaction, the chief executive officer owned 44,774 shares in the company, valued at $1,458,736.92. This represents a 28.76% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through this link. Company insiders own 8.50% of the company’s stock.

Global Medical REIT Price Performance

NYSE:GMRE opened at $35.90 on Tuesday. The firm’s fifty day moving average is $33.81 and its two-hundred day moving average is $34.19. The firm has a market cap of $481.42 million, a price-to-earnings ratio of -143.60 and a beta of 1.18. Global Medical REIT Inc. has a one year low of $29.05 and a one year high of $45.75. The company has a debt-to-equity ratio of 1.65, a quick ratio of 0.52 and a current ratio of 0.52.

Global Medical REIT (NYSE:GMREGet Free Report) last posted its earnings results on Tuesday, November 4th. The company reported $1.12 EPS for the quarter, topping the consensus estimate of $1.05 by $0.07. Global Medical REIT had a return on equity of 0.25% and a net margin of 0.79%.The firm had revenue of $37.23 million for the quarter, compared to analyst estimates of $38.15 million. Global Medical REIT has set its FY 2025 guidance at 4.500-4.600 EPS. Research analysts expect that Global Medical REIT Inc. will post 0.81 EPS for the current year.

Global Medical REIT Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, January 9th. Investors of record on Friday, December 19th were issued a dividend of $0.75 per share. The ex-dividend date of this dividend was Friday, December 19th. This represents a $3.00 dividend on an annualized basis and a yield of 8.4%. Global Medical REIT’s dividend payout ratio is -1,200.00%.

Analyst Upgrades and Downgrades

GMRE has been the subject of several recent research reports. Citigroup raised Global Medical REIT to an “outperform” rating in a research report on Monday, October 13th. Citizens Jmp raised shares of Global Medical REIT from a “market perform” rating to an “outperform” rating and set a $40.00 price target for the company in a research report on Monday, October 13th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Global Medical REIT in a research report on Monday, December 29th. JMP Securities set a $40.00 price objective on shares of Global Medical REIT and gave the stock a “market outperform” rating in a research note on Monday, October 13th. Finally, Robert W. Baird lowered their target price on shares of Global Medical REIT from $45.00 to $41.00 and set a “neutral” rating for the company in a research note on Tuesday, November 11th. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $41.50.

View Our Latest Stock Analysis on Global Medical REIT

About Global Medical REIT

(Free Report)

Global Medical REIT (NYSE: GMRE) is a real estate investment trust focused on owning and managing healthcare-related properties across the United States. The company acquires, develops and leases a diversified portfolio of medical office buildings, outpatient facilities, long-term care centers and other specialized healthcare real estate. By concentrating on essential healthcare assets, Global Medical REIT seeks to generate stable, long-term rental income under triple-net and modified gross lease structures.

Since its incorporation in 2016 and initial public offering in 2017, the company has pursued an acquisitive growth strategy targeting markets with strong demographic trends and limited supply of modern medical facilities.

Read More

Want to see what other hedge funds are holding GMRE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Global Medical REIT Inc. (NYSE:GMREFree Report).

Institutional Ownership by Quarter for Global Medical REIT (NYSE:GMRE)

Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.